PYRVINIUM PAMOATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for pyrvinium pamoate and what is the scope of freedom to operate?
Pyrvinium pamoate
is the generic ingredient in one branded drug marketed by Parke Davis and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for PYRVINIUM PAMOATE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,836 |
| DailyMed Link: | PYRVINIUM PAMOATE at DailyMed |
Recent Clinical Trials for PYRVINIUM PAMOATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Thomas Jefferson University | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for PYRVINIUM PAMOATE
US Patents and Regulatory Information for PYRVINIUM PAMOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | POVAN | pyrvinium pamoate | TABLET;ORAL | 012485-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | POVAN | pyrvinium pamoate | SUSPENSION;ORAL | 011964-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
